Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study

Abstract

Although there were differences in the frequency of occurrence, various adverse reactions were confirmed in using all 4 COVID-19 vaccines, even with the BNT162b2 (Pfizer-BioNTech) vaccine. Caution is needed, and further research should be continuously conducted.